Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Curr Opin Pulm Med. 2010 Jan;16(1):71-6. doi: 10.1097/MCP.0b013e3283323b73.
The goal of this review is to assess recent additions to the medical literature that contribute to the clinical question: 'How might diet act as a disease modifier in patients with asthma?' In vitro, animal, and epidemiologic data are presented as justification for interventional studies, which form the basis of clinical recommendations and decision-making.
A number of studies suggest roles for n-3 fatty acids, soy isoflavones, vitamin D, and antioxidants as modifiers of asthma severity. However, these studies are generally complicated by small sample sizes and either negative results or findings that are of questionable clinical significance.
The available literature regarding dietary manipulation as asthma therapy is largely unconvincing. Although mechanistic and epidemiologic studies provide a rationale for diet therapies, there are few interventional studies with positive, clinically relevant endpoints. Future studies must include sufficient numbers of well selected patients and measure effects on exacerbations, symptoms, lung function, and medication use.
本文旨在评估医学文献中的最新进展,以解答临床问题:“饮食如何影响哮喘患者的疾病进展?”本文从体外、动物和流行病学数据方面进行论证,为干预性研究提供了依据,这些研究为临床建议和决策提供了基础。
多项研究表明 n-3 脂肪酸、大豆异黄酮、维生素 D 和抗氧化剂在哮喘严重程度方面具有调节作用。然而,这些研究通常受到样本量小的影响,结果要么为阴性,要么临床意义不明确。
目前关于饮食干预作为哮喘治疗的文献大多没有说服力。尽管机制和流行病学研究为饮食疗法提供了理论依据,但具有阳性、临床相关终点的干预性研究很少。未来的研究必须纳入足够数量的精选患者,并评估其对哮喘发作、症状、肺功能和药物使用的影响。